| 20th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 19th May 2025 7:00 am |
RNS |
Blenrep for 2L+ multiple myeloma approved in Japan |
| 19th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 16th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 15th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 14th May 2025 7:00 am |
RNS |
GSK to acquire efimosfermin |
| 14th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 13th May 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 13th May 2025 12:56 pm |
RNS |
Update on belrestotug development programme |
| 13th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 12th May 2025 3:31 pm |
RNS |
Block listing Interim Review |
| 12th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 9th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 8th May 2025 5:15 pm |
RNS |
Director/PDMR Shareholding |
| 8th May 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 8th May 2025 11:15 am |
RNS |
Linerixibat GLISTEN pIII trial data at EASL |
| 8th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 7th May 2025 6:22 pm |
RNS |
Result of AGM |
| 7th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 6th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 2nd May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 1st May 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 1st May 2025 3:00 pm |
RNS |
Total Voting Rights |
| 1st May 2025 7:00 am |
RNS |
Nucala MATINEE data in COPD published in NEJM |
| 1st May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 30th Apr 2025 7:05 am |
RNS |
Transaction in Own Shares |
| 30th Apr 2025 7:00 am |
RNS |
1st Quarter Results |
| 29th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 28th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 25th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 24th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 23rd Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 22nd Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Apr 2025 4:13 pm |
RNS |
Blenrep licensed by UK MHRA |
| 17th Apr 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2025 7:10 am |
RNS |
Arexvy now ACIP recommended for 50-59 at risk |
| 17th Apr 2025 7:05 am |
RNS |
GSK 5-in-1 meningitis vaccine recommended in US |
| 17th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 15th Apr 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
